Literature DB >> 11754899

Increased expression of angiotensin-converting enzyme in retinas of diabetic rats.

Y Okada1, I Yamanaka, T Sakamoto, Y Hata, Y Sassa, H Yoshikawa, K Fujisawa, T Ishibashi, H Inomata.   

Abstract

PURPOSE: The aim of this study was to examine the localization and the changes in the amount of angiotensin-converting enzyme (ACE) and the relationship between the renin-angiotensin (RA) system and vascular endothelial growth factor (VEGF)/VEGF-receptor system in the retinas of diabetic rats.
METHODS: Immunohistochemical localization of ACE, VEGF, and VEGF-receptor fetal liver kinase-1 (Flk-1) was examined in cryosections of the retinas of streptozotocin-injected diabetic rats. A semi-quantitative comparison of diabetic rats with age-matched controls was also performed by counting the ACE- or Flk-1-positive vessels per microscopic field.
RESULTS: ACE immunoreactivity was localized in the retinal vessel walls, and the percentages of ACE-positive vessels were significantly increased in the retinas of diabetic rats maintained 3 to 5 months. Both VEGF and Flk-1 signals increased simultaneously with the increment of ACE immunoreactivity.
CONCLUSIONS: ACE, expressed in the retinal vessel walls, increases simultaneously with the increment of both VEGF and Flk-1 in the retinas of diabetic rats, suggesting that upregulation of ACE might play some role in the progression of diabetic retinopathy through the VEGF/VEGF receptor system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754899     DOI: 10.1016/s0021-5155(01)00412-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  7 in total

Review 1.  Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-( 1-12) Axis in the Pathogenesis of Diabetic Retinopathy.

Authors:  Mohammad Shamsul Ola; Abdullah S Alhomida; Carlos M Ferrario; Sarfaraz Ahmad
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

2.  Effect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats.

Authors:  Ik Soo Byon; Dong Hyun Lee; Eun Sook Jun; Min Kyu Shin; Sung Who Park; Ji Eun Lee
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 3.  Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms.

Authors:  Michael J Allingham; Priyatham S Mettu; Scott W Cousins
Journal:  Exp Eye Res       Date:  2019-08-31       Impact factor: 3.467

4.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

5.  Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats.

Authors:  N Horio; A C Clermont; A Abiko; T Abiko; B D Shoelson; S-E Bursell; E P Feener
Journal:  Diabetologia       Date:  2003-11-14       Impact factor: 10.122

6.  Protective effects of Morus alba leaves extract on ocular functions of pups from diabetic and hypercholesterolemic mother rats.

Authors:  H I H El-Sayyad; M A El-Sherbiny; M A Sobh; A M Abou-El-Naga; M A N Ibrahim; S A Mousa
Journal:  Int J Biol Sci       Date:  2011-06-04       Impact factor: 6.580

Review 7.  Ototoxic effects and mechanisms of loop diuretics.

Authors:  Dalian Ding; Hong Liu; Weidong Qi; Haiyan Jiang; Yongqi Li; Xuewen Wu; Hong Sun; Kenneth Gross; Richard Salvi
Journal:  J Otol       Date:  2016-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.